UNSPSC 51172318: Carglumic acid

This classification denotes an agent affecting blood and body fluid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5L0HB4V1EW. European Medicines Agency schedules Carglumic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20051. Carglumic acid generally arises in the molecular formula C6H10N2O5.

The term CARGLUMIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46.) Most nations schedule carglumic acid under HS 29241900 and SITC 51471. As of Q4 2014, CARGLUMIC ACID remains the US FDA Preferred Term for this commodity. Carglumic acid bears US NLM identifiers UMLS ID C1318649 and NCI Concept Code C76884. SMILES: C(CC(=O)O)C(C(=O)O)NC(=O)N.

UNSPSC 51172318 Carglumic acid is a Commodity code that in recent state and local procurement activity maps to offender drug testing and specimen collection services rather than the pharmaceutical product its name suggests. Collin County Community Supervision and Corrections Department in Texas is the primary recent issuing body under this code, soliciting comprehensive laboratory and field testing operations including immunoassay screening with LC/MS/MS or GC/MS confirmation, oral fluid and hair testing methodologies, and staffed collection sites. The work encompasses staffing, lab certification compliance (SAMHSA, Texas DPS, or CAP), electronic result reporting, and operation of randomized testing notification systems. Vendors must submit pricing on a per-test basis across three service models—screening only, confirmation after screening, and screening with automatic confirmation of positives—with no additional surcharges permitted and price reductions required if lower rates are offered to other customers.

Collin County Community Supervision and Corrections Department posted RFP 2026-327 on September 25, 2026, with proposals due July 23, 2026 at 2:00 p.m., seeking to award in whole or in part to multiple vendors. The estimated contract value is $600,000 over an initial two-year term commencing September 1, 2026, with three optional one-year renewal periods not to exceed five years total. Annual testing demand is approximately 25,031 tests comprising 5,452 five-panel screens, 18,006 six-panel screens, and ancillary testing, with collection sites in Plano and McKinney operating 8:00 a.m. to 5:00 p.m. Monday through Friday plus five Saturdays annually. Evaluation scoring weights vendor understanding and cost equally at 30 points each, firm qualifications at 25 points, and client references at 15 points, with optional Phase 2 demonstrations and interviews worth up to 30 additional points. Funding derives from Texas Department of Criminal Justice–Community Justice Assistance Division appropriations, subject to annual availability, and the anticipated award date is August 10, 2026.